ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC61350-500mg |
|
505-52-2 |
Tridecanedioic acid
|
0 | — | |
GC61349-5mL |
|
5 |
Tributyrin
|
0 | — | |
GC61348-50mg |
|
928659-17-0 |
Triazavirin
|
0 | — | |
GC61348-10mg |
|
928659-17-0 |
Triazavirin
|
0 | — | |
GC61348-5mg |
|
928659-17-0 |
Triazavirin
|
0 | — | |
GC61347-10mg |
|
1810734-44-1 |
TRC-766
|
0 | — | |
GC61347-5mg |
|
1810734-44-1 |
TRC-766
|
0 | — | |
GC61347-10mM (in 1mL DMSO) |
|
1810734-44-1 |
TRC-766
|
0 | — | |
GC61346-100mg |
|
2097132-93-7 |
trans-Pralsetinib
|
0 | — | |
GC61346-50mg |
|
2097132-93-7 |
trans-Pralsetinib
|
0 | — | |
GC61346-10mg |
|
2097132-93-7 |
trans-Pralsetinib
|
0 | — | |
GC61346-5mg |
|
2097132-93-7 |
trans-Pralsetinib
|
0 | — | |
GC61345-10mg |
|
— |
Transdermal Peptide Disulfide TFA
|
0 | — | |
GC61345-5mg |
|
— |
Transdermal Peptide Disulfide TFA
|
0 | — | |
GC61345-1mg |
|
— |
Transdermal Peptide Disulfide TFA
|
0 | — | |
GC61344-500mg |
|
1896-62-4 |
trans-Benzylideneacetone
|
0 | — | |
GC61343-10mg |
|
26145-55-1 |
trans-2-Hexadecenoyl-L-carnitine
|
0 | — | |
GC61342-100mg |
|
136186-07-7 |
TPC2-A1-N
|
0 | — | |
GC61342-50mg |
|
136186-07-7 |
TPC2-A1-N
|
0 | — | |
GC61342-25mg |
|
136186-07-7 |
TPC2-A1-N
|
0 | — | |